Homocyst(e)ine and cardiovascular disease: A systematic review of the evidence with special emphasis on case-control studies and nested case-control studies

International Journal of Epidemiology

Volumn 31, Issue 1, 2002, Pages 59-70

  Ford, Earl S ^a   Smith, S Jay ^b   Stroup, Donna F ^c   Steinberg, Karen K ^c   Mueller, Patricia W ^b   Thacker, Stephen B ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cardiovascular disease; Homocyst(e)ine; Meta analysis

Indexed keywords

HOMOCYSTEINE;

CARDIOVASCULAR DISEASE; COHORT ANALYSIS; EPIDEMIOLOGY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CHILD; COHORT ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; EMBASE; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDLINE; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; REVIEW; RISK ASSESSMENT;

EID: 0036208436     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/31.1.59     Document Type: Review

References (124)

1. Metabolic abnormalities detected in a survey of mentally backward individuals in northern Ireland
2. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
3. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
4. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background
5. Plasma homocysteine and coronary heart disease: Systematic review of published epidemiological studies
6. Homocysteine and cardiovascular disease
7. Homocyst(e)-ine and cardiovascular disease: A critical review of the epidemiologic evidence
8. Blood levels of homocysteine and increased risks of cardiovascular disease: Causal or casual?
9. Homocyst(e)inemia in daily practice: Levels in coronary artery disease
10. Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients
11. Association between plasma homocysteine and coronary artery disease in older persons
12. Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study
13. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: A population-based study
14. Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: Results from the Third National Health and Nutrition Examination Survey, 1988-1994
15. Methionine intolerance: A possible risk factor for coronary artery disease
16. The pathogenesis of coronary artery disease: A possible role for methionine metabolism
17. Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria
18. The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease
19. Relationship among homocyst(e)ine, vitamin B-12 and cardiac disease in the elderly: Association between vitamin B-12 deficiency and decreased left ventricular ejection fraction
20. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: Genetic-environmental interaction
21. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease
22. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydofolate reductase gene is a genetic risk factor for cardiovascular disease
23. Common mutation in methylenetetrahydrofolate reductase: Correlation with homocysteine metabolism and late-onset vascular disease
24. Low circulating folate and vitamin B6 concentrations: Risk factors for stroke, peripheral vascular disease, and coronary artery disease
25. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women
26. Evaluation of the measurement of lysate homocysteine in patients with symptomatic arterial disease and in healthy volunteers
27. Homocysteine and risk of cardiovascular disease among postmenopausal women
28. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: The Muscatine Study
29. Correlation between plasma homocyst(e)ine and aortic atherosclerosis
30. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study
31. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus
32. Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease
33. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria
34. Plasma homocysteine levels and mortality in patients with coronary artery disease
35. Hyperhomocysteinemia: An independent risk factor for vascular disease
36. Total plasma homocysteine determination in subjects with premature cerebral vascular disease
37. Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology
38. Family history and premature coronary heart disease
39. Homocysteine and risk of premature coronary heart disease: Evidence for a common gene mutation
40. Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study
41. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project
42. The medical review article: State of the science
43. Meta-analyses to evaluate analgesic interventions: A systematic qualitative review of their methodology
44. Invited commentary: A critical look at some popular meta-analytic methods
45. Validation of an index of the quality of review articles
46. Hyperhomocysteinemie chez des patients coronariens: A propos d'une étude portant sur 102 sujets
47. Moderate homocysteinemia -a possible risk factor for arteriosclerotic cerebrovascular disease
48. Plasma homocysteine in the acute and convalescent phases after stroke
49. Hyperhomocysteinaemia in black patients with cerebral thrombosis
50. Plasma homocyst(e)-ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease
51. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men
52. The diagnostic value of serum homocysteine concentration as a risk factor for coronary artery disease
53. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis
54. Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men
55. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease
56. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease
57. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis
58. Meta-analysis in clinical trials
59. Statistical Methods for Meta Analysis. Ch. 7: Fitting Parametric Fixed Effect Models to Effect Sizes: Categorical Models
60. An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data
61. Processing for outliers
62. Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: A 10-year follow-up
63. Homocysteine and ischaemic heart disease in the Caerphilly cohort
64. Homocysteine in frozen plasma samples: A short cut to establish hyperhomocysteinaemia as a risk factor for arteriosclerosis?
65. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study
66. Serum total homocysteine and coronary heart disease
67. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians
68. Homocyst(e)-ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial
69. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis
70. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The Atherosclerosis Risk in Communities (ARIC) Study
71. Homocysteine and ischemic heart disease: Results of a prospective study with implications regarding prevention
72. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: The Rotterdam Study
73. Serum total homocysteine and coronary heart disease: Prospective study in middle aged men
74. Protein-bound homocyst(e)ine: A possible risk factor for coronary artery disease
75. Homocysteine and myocardial infarction
76. Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease
77. Influence of hydrolysis on plasma homocysteine determination in healthy subjects and patients with myocardial infarction
78. Homocysteine and coronary artery disease in French Canadian subjects: Relation with vitamins B12, B6, pyridoxal phosphate, and folate
79. Plasma homocysteine in acute myocardial infarction: Homocysteine-lowering effect of folic acid
80. Homocysteinaemia after methionine overload as a coronary artery disease risk factor: Importance of age and homocysteine levels
81. Hyperhomocysteinemia and low pyridoxal phosphate: Common and independent reversible risk factors for coronary artery disease
82. Plasma homocyst(e)ine as a risk factor for early familial coronary artery Disease
83. Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease
84. Hyperhomocysteinaemia and premature coronary artery disease in the Chinese
85. Plasma homocyst(e)ine levels and graded risk for myocardial infarction: Findings in two populations at contrasting risk for coronary heart disease
86. Homocysteine metabolism and risk of myocardial infarction: Relation with vitamins B6, B12, and folate
87. Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases
88. Taux d'homocysteine sanguine chez les patients de moins de 55 ans, atteints d'insuffisance coronarienne aigue
89. Association between hyperhomocysteinemia and ischemic heart disease in Sri Lankans
90. Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease
91. Myocardial infarction in young women in relation to plasma total homocysteine folate and a common variant in the methylenetetrahydrofolate reductase gene
92. Plasma homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery
93. Plasma homocysteine levels in patients with coronary heart disease
94. Homocysteine levels and coronary heart disease in Syria
95. Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and the severity of coronary atherosclerosis in Koreans
96. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
97. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians
98. Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease
99. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham Study
100. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke
101. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction in hypertensive subjects
102. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease: Effects of pyridoxine and folic acid treatment
103. Abnormalities of hemostatis in ischemic stroke
104. Hyperhomocysteinaemia in stroke: Prevalence, cause, and relationships to type of stroke and stroke risk factors
105. Determinación de homocisteína en plasma por chromatografía líquida de alta resolución. Applicación al estudio de enfermos afectos de enfermedad vascular cerebral y periférica
106. A homocisteinemia como factor de risco de doenca vascular cerebral. A importancia da idade e dos niveis de homocisteinemia
107. Total plasma homocysteine determination by liquid chromatography before and after methionine loading. Results in cerebrovascular disease
108. Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia
109. Concentraciones plasmaticas de homocisteina en pacientes con infarto cerebral isquemico
110. Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke
111. Bias in meta-analysis detected by a simple, graphical test
112. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults
113. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis
114. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects
115. Association between plasma homocysteine and extracranial carotid arterial disease in older persons
116. Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study
117. Marginal folate deficiency as a possible cause of hyperhomocysteinaemia in stroke patients
118. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans
119. Prospective studies of homocysteine and cardiovascular disease
120. Total homocysteine in plasma or serum: Methods and clinical applications
121. Assessment of laboratory tests for plasma homocysteine-selected laboratories, July-September 1998